Accueil   Diary - News   All news CarThera to present data from phase 1/2a study

CarThera to present data from phase 1/2a study

Paris, France, May 10, 2017 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that Dr. Ahmed Idbaih, AP-HP principal investigator of the Phase 1/2a clinical trial (NCT02253212) on ultrasound induced Blood-Brain Barrier opening will reveal preliminary safety and efficacy data at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (June 2-6).




The clinical trial involved 21 patients with recurrent glioblastoma (GBM), who have all been treated with SonoCloud® low-intensity pulse ultrasound in a total of 65 sessions.



Read the press release